Success Metrics

Clinical Success Rate
100.0%

Based on 19 completed trials

Completion Rate
100%(19/19)
Active Trials
7(21%)
Results Posted
5%(1 trials)

Phase Distribution

Ph phase_1
1
3%
Ph phase_2
2
6%
Ph phase_3
1
3%
Ph not_applicable
18
53%
Ph phase_4
2
6%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
2(8.3%)
Phase 3Large-scale testing
1(4.2%)
Phase 4Post-market surveillance
2(8.3%)
N/ANon-phased studies
18(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

19 of 19 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

34

all time

Status Distribution
Active(9)
Completed(19)
Other(6)

Detailed Status

Completed19
Recruiting6
unknown6
Enrolling by invitation2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
34
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (4.2%)
Phase 22 (8.3%)
Phase 31 (4.2%)
Phase 42 (8.3%)
N/A18 (75.0%)

Trials by Status

completed1956%
active_not_recruiting13%
enrolling_by_invitation26%
recruiting618%
unknown618%

Recent Activity

Clinical Trials (34)

Showing 20 of 34 trialsScroll for more
NCT07495319Not Applicable

Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population

Completed
NCT04663750Phase 3

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Recruiting
NCT07165626Not Applicable

Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy

Enrolling By Invitation
NCT05658237Not Applicable

Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)

Active Not Recruiting
NCT05331664Phase 4

Dropless Pars Plana Vitrectomy Study

Recruiting
NCT07005323Not Applicable

Progression Suppression and Retinal Regression in VEGF-resistant AMD

Recruiting
NCT06990607Not Applicable

Compare PPV With and Without Silicone Oil in Managing Postoperative Endophthalmitis

Completed
NCT06927544Not Applicable

Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes

Enrolling By Invitation
NCT06559488Not Applicable

IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes

Completed
NCT05367193Not Applicable

3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes

Completed
NCT04192994Not Applicable

Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis

Completed
NCT06358664Not Applicable

Caffeine and Cataract After Pars Plana Vitrectomy

Recruiting
NCT06233500Not Applicable

Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study

Unknown
NCT04891991Phase 2

Intravitreal Infliximab for Proliferative Vitreoretinopathy

Completed
NCT05863312Not Applicable

REtinal Detachment Outcomes Study

Recruiting
NCT06133660

Influence of Intravitreal Aqueous Tamponade on Lens Status and Ocular

Completed
NCT06102109Not Applicable

Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique

Recruiting
NCT04089033

Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN)

Completed
NCT05561569Not Applicable

Air Versus Gas Tamponade in Primary Retinal Detachment

Unknown
NCT00735657Not Applicable

Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin Needle

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
34